Histogen - Company Presentation HD

Presented by: Gail Naughton, Ph.D., Chairman & CEO Histogen is a regenerative medicine company focused on stimulating stem cells in vivo through the administration of embryonic-like soluble and insoluble compositions secreted by hypoxia-induced multipotent stem cells in suspension cultures. The company currently uses its cell conditioned media (CCM) as an additive to anti-aging skin care products and as an injectable for hair growth. A pilot, Phase I/II, and physician sponsored clinical trial have all demonstrated safety as well as significant efficacy in hair regrowth at the 12 week and one year timepoint. A small molecular weight subfraction of the CCM induces apoptosis in over 20 human cancer cell lines. The company has a JV called PUR Biologics for use of the CCM and extracellular matrix components for orthopedic applications. One proprietary manufacturing process produces the two products simultaneously, each of which have multiple aesthetic and therapeutic applications, to create a robust product portfolio. For more information on the 2013 Stem Cell Meeting on the Mesa visit www.stemcellmeetingonthemesa.com